Showing results (841-850 of 941) with videos related to

Sort By:
Pageof 95
Urologic Oncology|October 15, 2024
Investigating the pattern of prostate specific antigen screening among E-cigarette smokers within the behavioral risk factor surveillance systemFilippo Dagnino, Zhiyu Qian, Muhieddine Labban, et al.
Psycho-Oncology|March 10, 2025
Mental Health Challenges in Cancer Survivors From Diverse Backgrounds During COVID-19 Pandemic: Insights From the All of Us Research ProgramZhiyu Qian, Mansoo Cho, Kevin Zhangxu, et al.
World Journal of Urology|March 24, 2019
Testosterone replacement therapy is associated with an increased risk of urolithiasisTyler R McClintock, Marie-Therese I Valovska, Nicollette K Kwon, et al.
JAMA Oncology|August 25, 2017
Adjuvant Chemotherapy vs Observation for Patients With Adverse Pathologic Features at Radical Cystectomy Previously Treated With Neoadjuvant ChemotherapyThomas Seisen, Asha Jamzadeh, Jeffrey J Leow, et al.
World Journal of Urology|June 28, 2018
Characterizing trends in treatment modalities for localized muscle-invasive bladder cancer in the pre-immunotherapy eraSean A Fletcher, Sabrina S Harmouch, Marieke J Krimphove, et al.
Macromolecules|September 6, 2021
Radical Addition to N,N-Diaryl Dihydrophenazine Photoredox Catalysts and Implications in Photoinduced Organocatalyzed Atom Transfer Radical PolymerizationDaniel A Corbin, Katherine O Puffer, Katherine A Chism, et al.
Clinical Genitourinary Cancer|July 3, 2026
Time to Treatment Initiation and Survival in Patients With Muscle-Invasive Bladder Cancer (MIBC)Andrea Piccolini, Marco Paciotti, Stephan M Korn, et al.
JNCI Cancer Spectrum|July 31, 2019
Comparing Long-Term Outcomes Following Radical and Partial Nephrectomy for cT1 Renal Cell Carcinoma in Young and Healthy IndividualsWei Shen Tan, Sebastian Berg, Alexander P Cole, et al.
Clinical Genitourinary Cancer|July 16, 2019
Variation in Positive Surgical Margin Status After Radical Prostatectomy for pT2 Prostate CancerWei Shen Tan, Marieke J Krimphove, Alexander P Cole, et al.
Prostate Cancer and Prostatic Diseases|December 1, 2019
Risk of dementia following androgen deprivation therapy for treatment of prostate cancerAnna Krasnova, Matthew Epstein, Maya Marchese, et al.
Pageof 95